August 2025
Welcoming Our 2025-26 Fellows
- Kim Firn, MD, MS – Neuro-Ophthalmology/Neurology
- Alexander Haueisen, MD – Glaucoma
- Saghar Bacheri, MD, PhD – Medical Retina
- Hyelin You, MD – Cornea and External Diseases
- Tatiana Rosenblatt, MD – Oculoplastics
- Ketaki Panse, MD – Medical Retina
Their expertise and passion will help shape the next generation of eye care.
Dr. Vikas Chopra Named to National Leadership Roles in Eye Health
We’re proud to share that Dr. Vikas Chopra, a leading glaucoma specialist at Doheny Eye Institute, has been selected for two major leadership roles in national vision organizations.
Dr. Chopra has been appointed to the Board of Directors of the American Board of Ophthalmology—the organization that oversees certification for eye doctors across the country. In this role, he’ll help shape the future of eye care by helping design and guide the rigorous exams that ophthalmologists must pass to prove their expertise. He’ll also lead efforts to improve how doctors deliver safe, high-quality care.
In addition, Dr. Chopra has been named Chair of the Glaucoma Panel for the American Academy of Ophthalmology’s Technology Assessment Committee. In this role, he’ll work with fellow experts to carefully evaluate new and existing eye care technologies—making sure they’re backed by strong scientific evidence and truly help patients.
These prestigious appointments reflect Dr. Chopra’s deep commitment to advancing eye care and protecting sight. We’re honored to have him as part of the Doheny team!
To read more about Dr. Chopra’s expertise in glaucoma, we encourage you to visit this link.
Be Our Partner in Vision Research
Depending on your goals, there are several gift options for you to consider:
Cash Donations
Cash donations are easily made by credit card through our website. Alternatively, you can mail a check to Doheny Eye Institute, Development Department, 150 N. Orange Grove Blvd., Pasadena, CA 91103.
Company Matching
Make your generous gift go further by checking to see if your employer offers donation matching. Some employers will help double your gift. Visit our Donations page at this link to check whether your employer will match your donation.
Gifts of Appreciated Assets
Gifts of appreciated assets (stocks, bonds and mutual funds) can be accepted by Doheny and transferred to Doheny directly from your broker. If you have questions, please call us at or email us at .
Planned Gifts
It’s never too early to start planning your future legacy by making estate provisions to share a meaningful gift. Visit our Planned Giving page at this link to learn more or call Heidi Simpson-Sandoval at .
The generosity of our donors makes it possible to secure the resources, funding, and state-of-the-art equipment that enable Doheny scientists to work towards finding treatments for numerous diseases that cause vision impairment and blindness. We invite you to be our partner in helping to make a difference in the lives of millions of people worldwide.
Deborah Ferrington, PhD, Featured on Panel of Experts for the Greater Los Angeles Life Science Forum
On July 17, Doheny’s Chief Scientific Officer, Deborah Ferrington, PhD, participated in a panel discussion on The Role of Research Institutions at the fourth annual Greater Los Angeles Life Science Forum. The day-long conference convened leaders from industry, government, academia, and the broader life science community to explore what research institutions are, who they are in Los Angeles, and how they are shaping the region’s life science ecosystem.
Dr. Ferrington was joined on the panel by representatives from several of Southern California’s leading institutions: Nirdesh Gupta, PhD, Managing Director of Cedars-Sinai Technology Ventures; Denica Moodley, MPH, Director of Operational Transformation and Innovation at Children’s Hospital Los Angeles; and Joe W. Ramos, PhD, President & CEO of The Lundquist Institute. The discussion was moderated by Jonathan Thomas, PhD, JD, President & CEO of the California Institute for Regenerative Medicine.
The Life Science Forum brings together approximately 200 regional stakeholders each year to highlight the latest developments driving innovation in Los Angeles’ life sciences sector. The conference underscores the economic vision of regional leaders, showcases emerging startups launched from academic institutions, and emphasizes the importance of workforce development in improving health outcomes and regional competitiveness.
Doheny’s participation on the panel provided an opportunity to spotlight the institute’s pioneering research and its impact on patients living with vision loss and eye disease.